Liver Health
Natural health product licensed in Canada
- Other names
- HepatPro
- Licence holder
- Canadian NHPs Enterprises Corp.
- NPN or DIN-HM
- 80041890
- Status
- Active licence
- Licence date
- 24 April 2013
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 20 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Poisson d'huile de foie de morue-Foie | 5 mcg | 20 µg |
| Vitamine D Source : Cholécalciférol | 5 mcg | 20 µg |
Non-medicinal ingredients
Maltodextrine, Stéarate de magnésium, Hypromellose, Curcumine, Cellulose microcristalline, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 days |
Uses authorised in Canada
Help(s) to support liver function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Do not use if you have gallstones, liver or gall bladder disorders and a bile duct or bowel obstruction. Discontinue use if you develop symptoms of liver trouble.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking antiplatelet medication or blood thinners. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. Do not use if you are pregnant. Consult a health care practitioner prior to use if you are breastfeeding.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use. May occasionally cause heartburn, acid ingestion, stomach pain, anorexia, allergic skin rashes and urticarial. Individuals with high gastric acidity or peptic ulcers may experience increased acidity. in which case, discontinue use.
Source
Official Health Canada record, licence 80041890
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.